Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Assets (2018 - 2025)

Historic Return on Assets for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to 0.33%.

  • Autolus Therapeutics' Return on Assets changed 0.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.38% for FY2024, which is 1000.0% up from last year.
  • Latest data reveals that Autolus Therapeutics reported Return on Assets of 0.33% as of Q3 2025, which was down 0.0% from 0.31% recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Return on Assets ranged from a high of 0.27% in Q2 2024 and a low of 143.02% during Q3 2021
  • Moreover, its 5-year median value for Return on Assets was 0.37% (2023), whereas its average is 27.64%.
  • In the last 5 years, Autolus Therapeutics' Return on Assets tumbled by -1425300bps in 2021 and then soared by 1425700bps in 2022.
  • Over the past 5 years, Autolus Therapeutics' Return on Assets (Quarter) stood at 127.77% in 2021, then soared by 100bps to 0.39% in 2022, then tumbled by -35bps to 0.53% in 2023, then surged by 49bps to 0.27% in 2024, then decreased by -19bps to 0.33% in 2025.
  • Its Return on Assets stands at 0.33% for Q3 2025, versus 0.31% for Q2 2025 and 0.31% for Q1 2025.